First-of-a-kind drug approvals continued rise in 2015
The rising figures reflect an industry-wide focus on drugs for rare and hard-to-treat diseases, which often come with streamlined reviews, extra patent protections and higher price tags.
The rising figures reflect an industry-wide focus on drugs for rare and hard-to-treat diseases, which often come with streamlined reviews, extra patent protections and higher price tags.
A jury awarded $15 million in damages to Crystal and Jamie Bobbitt in their lawsuit against a doctor and a hospital. They’ve not yet received any of that money, and their attorneys are challenging the constitutionality of the state’s malpractice law.
Despite national attention paid to RFRA and Jared Fogle, most of IBJ’s top-read online stories this year were the result of deeply sourced reporting on people, issues and businesses specific to central Indiana.
A professor in the Indiana School of Medicine is hopeful that an antibiotic cocktail he invented will one day improve the lives of millions of people, thanks in part to the Indiana University Research and Technology Corp., formed in 1997 to make work done by IU faculty and researchers available for commercial development.
IU Health effectively started its own ambulance service in December by adding two ambulances to its long-standing LifeLine critical-care service and opening a call center to help other health care providers figure out what level of transport services a particular patient needs.
Pat Fox, president and CEO of Riverview Health since 2004, plans to retire in May, the Noblesville-based health care network announced Monday.
The founder of an Indianapolis medical facility said Monday that a former unpaid student intern who claimed Peyton Manning used a banned substance in 2011 didn't even work at the clinic until two years later.
The report from Al Jazeera claims the star quarterback received human growth hormone from the Guyer Institute, an Indianapolis anti-aging clinic.
Even excluding the 78.8 million records stolen from health insurer Anthem, the number of patient records stolen from Indiana health care organizations spiraled to 4.3 million from about 69,000 in 2014.
The fast-but-fresh restaurant chain plans to change the way it handles its meats, vegetables and cheese to combat a hit to its image from incidences of foodborne illness.
Carmel-based Nightingale Home Healthcare Inc., which serves nearly 900 Hoosier patients, filed for Chapter 11 bankruptcy protection and won court approval to borrow $350,000 from its parent company to make payroll.
Indiana lawmakers have yet to gather for the 2016 legislative session, but a fight is shaping up over a proposed law that would require a prescription to buy a common cold medicine also used to make methamphetamine.
The state’s largest hospital system will promote IU Health Arnett President Al Gatmaitin president to chief operating officer, replacing Dennis Murphy, who is set to become CEO in April.
Despite its low cost of living, Indianapolis is among the highest-priced areas for hospital services for patients with private health insurance—and is far more costly than Boston, Chicago, Manhattan and Los Angeles, according to a new study.
The proposed merger of Dow Chemical Co. and DuPont Co. would create the world’s largest agricultural-products company. But that’s bad news for farmers, according to some farm groups and antitrust experts.
The FDA said Wednesday it approved Basaglar based on data showing it is safe and effective and works similarly to Lantus, the world’s top-selling insulin.
The American Lung Association, American Heart Association and Tobacco Free Indiana all issued statements Wednesday applauding the possibility and calling for an increase of at least $1 per pack of cigarettes.
The Pence administration’s decision to spend $120 million on a new psychiatric hospital represents a stark shift from the state’s approach to mental health of the past 30 years.
As the Affordable Care Act enters its third year with enrollment well behind schedule, procrastinators are critical to its economic viability.
A new study says women who took a common class of antidepressants during the second and third trimesters were more than twice as likely than other women to have children who later developed autism.